Epigenetic activation of the FLT3 gene by ZNF384 fusion confers a therapeutic susceptibility in acute lymphoblastic leukemiaXujie Zhao, Jun J. Yang, Kelly R. Barnett et al.|Nature Communications|2022Cited by 27
Epigenomic mapping reveals distinct B cell acute lymphoblastic leukemia chromatin architectures and regulatorsKelly R. Barnett, Daniel Savic|Cell Genomics|2023Cited by 14
Differentiation-dependent EBF1 activity determines <i>CD22</i> transcription and leukemia sensitivity to inotuzumab ozogamicinCarolin S. Escherich, Jun Yang, Zhenhua Li et al.|Blood|2025Cited by 5
Functional investigation of inherited noncoding genetic variation impacting the pharmacogenomics of childhood acute lymphoblastic leukemia treatmentKashi Raj Bhattarai, Daniel Savic|medRxiv|2023Cited by 0